Applied Therapeutics(Aplt) Financials: Receivables Turnover Compared To Industry Average, Plus Other Key Ratios
Growth Trend (Last 5 Years)
Growth - receivables turnover
This chart shows the historical trend of receivables turnover for APLT compared to its industry average over the recent years.
Ratio Definition and Interpretation
Name: Receivables Turnover
Definition: Receivables turnover tells you how quickly the company collects payments from customers after making sales on credit. A high turnover means customers pay on time and cash flows smoothly. Slow turnover suggests delayed collections, which can create cash shortages and financing stress.
Interpretation:
• In '2021', APLT's receivables turnover was 0.00, showing efficiency in collecting outstanding receivables. Industry average for Biotechnology: Pharmaceutical Preparations in '2021' stood at 2.42.
• In '2022', APLT's receivables turnover was 0.00, showing efficiency in collecting outstanding receivables. The figure remained stable compared to '2021'. Industry average for Biotechnology: Pharmaceutical Preparations in '2022' stood at 2.48. Industry average increased by 0.06 compared to previous year.
• In '2023', APLT's receivables turnover was 35.69, showing efficiency in collecting outstanding receivables. The increase since '2022' reflects strengthening financial performance. Industry average for Biotechnology: Pharmaceutical Preparations in '2023' stood at 2.34. Industry average declined by 0.14 from previous year.
Overall, APLT's receivables turnover has been volatile but showed an upward trend over the past 3 years.
Formula: Receivables Turnover = Net Credit Sales / Average Accounts Receivable
Good Range: Ranges 5 to 15 depending on credit terms.